000 01333 a2200373 4500
005 20250516115921.0
264 0 _c20130207
008 201302s 0 0 eng d
022 _a1096-9896
024 7 _a10.1002/path.4127
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJanssen, Wiebke
245 0 0 _aThe role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis.
_h[electronic resource]
260 _bThe Journal of pathology
_cJan 2013
300 _a242-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAmidohydrolases
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aArginine
_xanalogs & derivatives
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aIdiopathic Pulmonary Fibrosis
_xdrug therapy
650 0 4 _aLung
_xdrug effects
650 0 4 _aNitric Oxide
_xmetabolism
650 0 4 _aNitric Oxide Synthase Type II
_xantagonists & inhibitors
650 0 4 _aSignal Transduction
700 1 _aPullamsetti, Soni Savai
700 1 _aCooke, John
700 1 _aWeissmann, Norbert
700 1 _aGuenther, Andreas
700 1 _aSchermuly, Ralph Theo
773 0 _tThe Journal of pathology
_gvol. 229
_gno. 2
_gp. 242-9
856 4 0 _uhttps://doi.org/10.1002/path.4127
_zAvailable from publisher's website
999 _c22211803
_d22211803